Posts by: Patricia Inacio, PhD

Patricia Inacio, PhD

June 10, 2019

High Levels of ‘Bad’ Cholesterol Linked to Increased Risk of Early-onset Alzheimer’s, Study Suggests

News

High levels of “bad” cholesterol, known as low-density lipoprotein (LDL), might increase the risk of developing early-onset Alzheimer’s disease, a study suggests. The study, “Association of Early-Onset Alzheimer Disease ... Read more

June 3, 2019June 3, 2019

Virtual Reality May Improve Quality of Life of Hospitalized Dementia Patients, Study Says

News

Virtual reality may help improve the quality of life for people with dementia, including those with Alzheimer’s disease, by stimulating them to recall past memories, reduce aggressive behavior, and ... Read more

May 8, 2019May 8, 2019

Tetra Launches Phase 2 Trial Testing Treatment to Improve Working Memory in Older Patients

News

Tetra Discovery Partners is launching a Phase 2 clinical trial for BPN14770 — found to improve working memory in older patients in earlier trials — as a treatment for ... Read more

May 6, 2019May 6, 2019

#AANAM – Memantine as Add-on Therapy Seen to Ease Psychosis, Other Advanced Alzheimer’s Symptoms

News

Adding memantine to a cholinesterase inhibitor can significantly ease certain neuropsychiatric symptoms, including psychosis and troubling motor or nighttime behavior, in people with moderate-to-severe Alzheimer’s disease, according to pooled ... Read more

May 1, 2019May 1, 2019

Long-term Treatment with Thiazide Diuretics May Lower Risk of Bone, Hip Fractures, Study Suggests

News

Long-term use of thiazide diuretics — a hypertension medication — may lower the risk of bone fractures, particularly hip fractures, in people with Alzheimer’s, a disease with a high ... Read more

April 29, 2019April 29, 2019

Simple Blood Test May Become Useful Biomarker of Alzheimer’s Progression and Treatment Response, Study Suggests

News

Blood levels of a nerve cell-derived component, known as neurofilament light chain, could be used as a biomarker of disease severity and treatment response in patients with Alzheimer’s disease, ... Read more

April 22, 2019April 22, 2019

Cognitive Training Improves Reasoning and Memory in Adults with Mild Impairment, Pilot Study Finds

News

Cognitive training alone — without the use of direct brain stimulation — may significantly benefit adults with mild cognitive impairment, a known risk factor for Alzheimer’s disease, a pilot ... Read more

April 15, 2019April 15, 2019

Toll of Family Caregiving on Health is Much Smaller Than Previously Reported, Study Suggests

News

While caregiving for people with Alzheimer’s and other disorders has a significant detrimental impact on caregivers’ immune system, the association is weak — less than 1% — and may ... Read more

April 10, 2019April 15, 2019

Phase 1 Trial of Alzheimer’s Candidate SM07883 Doses First Participant

News

A Phase 1 trial evaluating Samumed’s investigational compound SM07883 for Alzheimer’s disease has dosed its first participant. The Phase 1 trial (ACTRN12619000327189), taking place in Australia, will assess the ... Read more

April 8, 2019April 8, 2019

Investigational Azeliragon May Lessen Cognitive Decline in Mild Alzheimer’s Disease Patients with Type 2 Diabetes, Analysis Finds

News

The investigational therapy azeliragon decreased inflammation and lessened cognitive decline and dementia in patients with mild Alzheimer’s disease and type 2 diabetes, compared with a placebo, according to data from ... Read more

Pin It on Pinterest